Foghorn Therapeutics Inc. Ratios

Ratios Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
EBT Margin 9,560.00%-16,165.12%-7,777.18%-566.27%-275.80%-383.24%
EBIT Margin 9,460.00%-15,937.44%-7,637.15%-609.20%-315.93%-454.31%
EBITDA Margin 9,468.15%-16,001.63%-7,681.80%-586.95%-278.92%-378.99%
Operating Margin 9,460.00%-15,937.44%-7,637.15%-609.20%-315.93%-454.31%
Net Margin 9,560.00%-16,165.12%-7,777.18%-566.27%-288.17%-383.24%
FCF Margin 8,759.81%-11,039.30%-4,060.88%1,000.63%-349.38%-448.24%
Efficiency
Assets Average 387.68M462.33M345.40M284.95M
Equity Average 121.53M48.49M-38.54M-61.36M
Invested Capital 165.84M96.87M0.11M-77.19M-45.53M
Asset Utilization Ratio 0.000.040.100.08
Leverage & Solvency
Interest Coverage Ratio -94.60-70.00-52.85
Debt to Equity 0.13
Debt Ratio 0.08
Equity Ratio 0.570.190.00-0.27-0.16
Times Interest Earned -94.60-70.00-52.85
Valuation
Enterprise Value 633.15M747.15M214.48M191.96M206.95M
Market Capitalization 725.94M848.28M266.70M272.30M262.40M
Return Ratios
Return on Sales 95.60%-161.65%-77.77%-5.66%-2.88%-3.83%
Return on Capital Employed -0.30%-0.29%-0.38%-0.47%
Return on Assets -0.26%-0.24%-0.28%-0.30%
Return on Equity -0.84%-2.25%2.55%1.41%